Results of the Randomized Phase 3 AFU-GETUG-20 Trial Evaluating Adjuvant Leuprorelin Acetate After Radical Prostatectomy in Men with High-risk Localized Prostate Cancer

European Urology Oncology 2026

View at publisher
Authors: François Rozet, A. Ruffion, Pablo Lemercier, Michel Soulié, G. Robert, Jochen Christoph Walz, Alexandre De La Taille, Laurent Salomon, Christian U. Pfister, Romain Mathieu, S. Vincendeau, Aurelien Descazaud
+42 more I. Latorzeff, Laurent Brureau, Marc COLOMBEL, Morgan Rouprêt, Lise Roca, Christelle Pérez, Sebastien Marion, Éric Barret, Xavier Cathelineau, Karim Fizazi, Stéphane Culine, Antony Cicco, Arnaud Villers, Bertrand D. Guillonneau, Cyrille Bastide, Emmanuel Van Glabeke, Franck Bruyère, Franck Duchêne, F. Kleinclauss, Hervé Lang, Jean François Berdah, J. Rigaud, Jorge Villamizar, Luc Corbel, Marc Schneider, Michaël Peyromaure, Mounira El Demery, Nicolas Mottet, Pascal Blanchet, Patrick J. Coloby, Pierre Auberdiac, Pierre Guillet, Pierre Mongiat-Artus, Richard Pierre Gaston, Stéphane Droupy, Stephane Gilles Guerif, Marc COLOMBEL, Paul Sargos, Alexandre Colau, Pierre Cornillon, Nita Usdin, Xavier Tchiknavorian
DOI: 10.1016/j.euo.2025.11.009
Cited by: 0
References: 20

Fields of Study & Subjects

Prostate Cancer Diagnosis and Treatment Prostate Cancer Treatment and Research Urinary Bladder and Prostate Research

Publication details

Journal / source
European Urology Oncology
Volume
9
Issue
2
Pages
369–377
Publication date
3 January 2026
Language
EN